Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Nuvectis Pharma Inc., 3 years.
Nuvectis Pharma Inc.
Director
TG Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | Nuvectis Pharma Inc. | Grant or award | +35,000 | — | — |
| Jun 12, 2025 | TG Therapeutics Inc. | Grant or award | +14,718 | — | — |
| Jun 12, 2025 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Jun 19, 2024 | TG Therapeutics Inc. | Grant or award | +22,250 | — | — |
| Jun 13, 2024 | Nuvectis Pharma Inc. | Grant or award | +30,000 | — | — |
| Sep 28, 2023 | TG Therapeutics Inc. | Grant or award | +20,000 | — | — |
| Jun 16, 2023 | Nuvectis Pharma Inc. | Grant or award | +18,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.